Alexa Blume is a Director at Axsome Therapeutics, managing clinical trials for novel immunotherapeutic agents. An experienced leader in clinical operations, she has progressed through multiple roles within the company. Her background from Rutgers University in Cell Biology and Neuroscience supports her work in R&D.
Outside of her clinical trial work, Alexa maintains a keen interest in the broader pharmaceutical landscape. She follows industry leaders like Novo Nordisk and stays informed on market trends through publications such as The Wall Street Journal.
Her entire post-university career has been dedicated to Axsome Therapeutics, showcasing a remarkable trajectory from a coordinator role to Director.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.